Those findings were further supported by Li and his colleagues, who demonstrated that TGF-β1, a potent keratinocyte growth inhibitor, has been shown to be overexpressed in keratinocytes in certain inflammatory skin diseases, thus counteracting the effects of other growth factors at the site of inflammation [39]. Here, TGFB1 is linked to inflammatory skin disease.